This MTE session will focus on implementing hepatitis C virus screening and linkage to care during pregnancy. Topics will include partnering with ob/gyn to provide hepatitis C screening, approaches to counseling and treatment of pregnant people with hepat
The aim is to discuss metabolic alterations that are involved in liver fibrosis and portal hypertension.
This session will focus on how Northwestern built a liver transplant program that sought to mitigate disparities for Hispanic and Black patients.
Frailty is a predictor of worse outcome in patients with cirrhosis. This program will discuss the assessment of frailty in the outpatient setting.
What is the future of microbiome research in autoimmune liver disease? In this session, we’ll review the role of the microbiome in autoimmune disease progression and outcomes and share what might be next in gut health research. We’ll also review a few of
MTE to understand the best strategies for surveillance and management of hepatobiliary cancers in patients with PSC particularly cholangiocarcinoma
Faculty will discuss risk of HCC in emerging at-risk populations for HCC, including patients with MASLD and those who are post-SVR. We will specifically address the controversy regarding HCC risk and benefits of HCC surveillance in patients with advanced
Review common benign liver lesions and their management.
The PharmD is an integral part the multidisciplinary team. In this session you will gain insight from a PharmD on their unique role as a member of the Hepatology and Transplant team in improving patient outcomes.